Alison Cave
Dr. Alison Cave is the chief safety officer at the UK's Medicines and Healthcare products Regulatory Agency (MHRA). She is responsible for overseeing the regulation of medicines and ensuring public safety regarding their use. In light of recent botulism cases associated with Botox, she has been vocal about the illegal sale of such products and the importance of receiving treatments from licensed practitioners.
Not in the pool (under ¢1).
Recent news mentions
Alison Cave, the director of the UK's Medicines and Healthcare products Regulatory Agency, reinforced the warning regarding the risk of pancreatitis associated with certain medications.
Crece la preocupación por un posible efecto adverso grave de las inyecciones para adelgazar: los síntomas
Argentina· 2026-02-22
Dr Alison Cave warned that untreated pain and fever can pose risks to the unborn baby.
‘Pay no attention’: global health agencies dismiss false Trump claim on everyday painkillers | Health
United Kingdom· 2025-09-24
Alison Cave emphasized the well-established safety profile of hepatitis B vaccines in the UK.
International health agencies hit back against Trump’s claims about Tylenol and autism
United States· 2025-09-23
Alison Cave, responsible for safety at MHRA, calculates that a third of adverse reactions could be prevented with prior genetic testing.
Pancreatitis, Ozempic y titulares exagerados: una alerta en el Reino Unido despierta dudas sobre el abuso del fármaco | Salud y bienestar
Spain· 2025-07-03
Dr Alison Cave, the MHRA's chief safety officer, said information from the study will help predict those most at risk of adverse reactions.
Weight loss jabs study begins after reports of pancreas issuesUnited Kingdom· 2025-06-26
Dr Alison Cave, the MHRA’s chief safety officer, emphasized the importance of genetic testing in preventing side effects from medications.
Hundreds of weight loss and diabetes jab users in UK report pancreas problems – The Irish Times
Ireland· 2025-06-26Dr. Alison Cave, chief safety officer at MHRA, stated that botulinum toxin (Botox) should only be available under the supervision of a qualified healthcare professional.
Botulism: Dozens in northeast England report symptoms of potentially deadly botulism after getting BotoxUnited States· 2025-06-21
